NCT06392854View on ClinicalTrials.gov

Regional Lipolysis Insulin Regulation

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Obesity
Interventions
DRUG

Insulin

2 dose insulin infusion 4 hours

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT06392854 - Regional Lipolysis Insulin Regulation | Biotech Hunter | Biotech Hunter